chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the right arm on 28Apr2021 at 15:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included depression, migraines and high blood pressure. The patient did not have any known allergies. Concomitant medications included escitalopram (MANUFACTURER UNKNOWN); bupropion (MANUFACTURER UNKNOWN); hydrochlorothiazide (MANUFACTURER UNKNOWN) and naloxone hydrochloride;buprenorphine hydrochloride (SUBOXONE); all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0153) via an unspecified route of administration in the left arm on 07Apr2021 at 15:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 29Apr2021 at 09:00, the patient experienced extreme fatigue lasting four days post second COVID vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event extreme fatigue was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vitreous floaters
Clinical narrative: Floaters in left eye which I have never had in my life. These appeared the next day after 1st shot.; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 00:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (SYNTHROID) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Apr2021 at 10:00, the patient had floaters in left eye which she never had in her life. These appeared on the next day after 1st shot and made her nervous to get second shot. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event floaters in left eye which she had never had in her life, these appeared the next day after 1st shot was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Bone disorder, Joint noise, Pain in extremity
Clinical narrative: Bones and joints popping, snapping and clicking; Bones and joints popping, snapping and clicking; pain in joints and fingers; pain in joints and fingers; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration, administered in left shoulder on 25Apr2021 at the age of 59 years old as a single dose for COVID-19 immunisation. The patient's medical history included Cholecystectomy from 31Mar2021. The patient's concomitant medications were not reported. The patient had not visited emergency room or physician office due to the event. On an unspecified date the patient experienced Bones and joints popping, snapping and clicking, pain in joints and fingers. The reporter reported that the same time as the popping, snapping, and clicking. It happened kind of after use, and after doing physical activity. The pain had stayed the same. NDC was unknown, does not have vaccine card or any thing with this information on it. The patient reported the time vaccination was given in mid morning. The patient had received the first dose of Pfizer vaccine probably 13 days, for this way the patient had second shot in 2 days, now his concern was since patient had the shot, the first shot all joints keep popping, like just popping, and clicking. The patient concerned was if he felt that it was a side effects and if the patient had the second shot will this get worst, or like patient was trying to pause of what we get from the second shot, or not which is due in 2 days, every time the patient move, click every time move his neck, knees, fingers, elbows, and knees it just keep clicking. The patient did not receive any treatment for events. The outcome of the events was not recovered.  The caller was provided with phone number and hours of operation for COVID-19 vaccine inquiries, prior to warm transfer.  Follow-up on 03May2021, This is a follow up spontaneous report from a contactable consumer included Patient's information, age at vaccination, and concomitant medication information updated.  Follow-up attempts are completed. information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Influenza like illness, Myalgia
Clinical narrative: Fatigue; Flu like sx; Headache; High fever; Diarrhea; Muscle pain; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 27-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 01May2021 at 11:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had known allergies to seafood. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ascorbic acid (VITAMIN C) and zinc (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 09Apr2021 at 11:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 01May2021, the patient experienced fatigue, flu like symptoms (sx), headache, high fever, diarrhea and muscle pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measure was taken as a result of the events which included treatment with paracetamol (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, flu like sx, headache, high fever, diarrhea and muscle pain was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fatigue; Flu like sx; Headache; High fever; Diarrhea; Muscle pain; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 27-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 01May2021 at 11:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had known allergies to seafood. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ascorbic acid (VITAMIN C) and zinc (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 09Apr2021 at 11:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 01May2021, the patient experienced fatigue, flu like symptoms (sx), headache, high fever, diarrhea and muscle pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measure was taken as a result of the events which included treatment with paracetamol (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, flu like sx, headache, high fever, diarrhea and muscle pain was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pain
Clinical narrative: Severe chills; Body aches; Fever; severe headache; Extremely tired; This is a spontaneous report from a non-contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the right arm on 01May2021 at 07:45 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included cancer survivor and known allergies to penicillin, bee stings and adhesive. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 10Apr2021 at 08:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 02May2021 at 13:00, the patient experienced severe chills, body aches, severe headache, fever of 101 and was extremely tired. On 02May2021, the patient underwent lab test and procedure which included body temperature and the result was 101(unspecified units). No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe chills, body aches, severe headache, fever of 101 and extremely tired was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Severe chills; Body aches; Fever; severe headache; Extremely tired; This is a spontaneous report from a non-contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the right arm on 01May2021 at 07:45 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included cancer survivor and known allergies to penicillin, bee stings and adhesive. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 10Apr2021 at 08:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 02May2021 at 13:00, the patient experienced severe chills, body aches, severe headache, fever of 101 and was extremely tired. On 02May2021, the patient underwent lab test and procedure which included body temperature and the result was 101(unspecified units). No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe chills, body aches, severe headache, fever of 101 and extremely tired was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: My period was late and only 1 day long, normally 5 days long.; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 16:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included escitalopram oxalate (LEXAPRO) and ethinylestradiol / norethisterone acetate (JUNEL) for unknown indication from unknown date and unknown if ongoing. On 29Apr2021, the patient's period was late and only 1 day long, normally 5 days long. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event period was late and only 1 day long, normally 5 days long was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: 'My' period is late by 3 weeks at the time of this report.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 11:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as none. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 12Apr2021, the patient's period was late by 3 weeks at the time of this report. The patient reported that usually it was very regular and had confirmed that she was not pregnant. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event period was late by 3 weeks was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymph node pain, Lymphadenopathy, Vaccination site pain
Clinical narrative: Swollen lymph nodes on left side of neck from clavicle to mandible.; Painful lymph nodes throughout body (bilateral neck, sides of breasts, along sides of spine and sternum, around rib cage, lower abdominal wall, and bilateral groin).; I also have a mild headache; Severe fatigue; Injection site pain; This is a spontaneous report from a contactable healthcare professional, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 13:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and COVID-19. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. Concomitant medications included clonazepam (MANUFACTURER UNKNOWN) and colecalciferol (VIT D3); both for unknown indication from unknown date and unknown if ongoing. The patient did not receive other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 13:45, the patient experienced swollen lymph nodes on left side of neck from clavicle to mandible. The patient had painful lymph nodes throughout her body (bilateral neck, sides of breasts, along sides of spine and sternum, around rib cage, lower abdominal wall, and bilateral groin). The patient also had a mild headache, severe fatigue, and injection site pain. It had been 5 days, so far.  Patient mentioned that her doctor told if she was not better by 06May2021, she would have to be seen again for blood work testing, and possible treatment. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes on left side of neck from clavicle to mandible, painful lymph nodes throughout body, mild headache, severe fatigue, and injection site pain was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache, Myalgia
Clinical narrative: In the arm where "I" got the shot pain; In the arm where "I" got the shot redness; In the arm where "I" got the shot swelling; Tiredness; Headache; Muscle pain; Chills; Diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the arm on 30Apr2021 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetic. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 30Apr2021 at 19:00, the patient experienced pain, redness and swelling in the arm where the patient got the shot and tiredness, headache, muscle pain, chills and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain, redness and swelling in the arm where patient got the shot and tiredness, headache, muscle pain, chills and diarrhea were resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: In the arm where "I" got the shot pain; In the arm where "I" got the shot redness; In the arm where "I" got the shot swelling; Tiredness; Headache; Muscle pain; Chills; Diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the arm on 30Apr2021 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetic. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 30Apr2021 at 19:00, the patient experienced pain, redness and swelling in the arm where the patient got the shot and tiredness, headache, muscle pain, chills and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain, redness and swelling in the arm where patient got the shot and tiredness, headache, muscle pain, chills and diarrhea were resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular
Clinical narrative: Periods every two weeks; Heavy bleeding; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration on 09Mar2021 at 02:45 (at the age of 27-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 30Mar2021 at 14:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On an unknown date in 2021, the patient experienced periods every two weeks and heavy bleeding. The clinical outcome of the events periods every two weeks and heavy bleeding were unknown at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Migraine with aura, Muscular weakness
Clinical narrative: Triggered migraine with aura. My migraines usually start with reduced vision (like when your eyes are tired) and this was triggered while driving an hour and a half after I received my first dose. tiredness; mild muscle weakness in the shoulder the shotwent in; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 06May2021 at 17:45 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included occasional migraine and COVID-19 ( Prior to the vaccination, the patient was diagnosed with COVID-19). Concomitant medications included etonogestrel (NEXPLANON IMPLANT) left arm, ibuprofen (ADVIL) and fluticasone propionate (FLONASE); all on an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06May2021 at 19:00 the patient experienced triggered migraine with aura, her migraines usually start with reduced vision (like when your eyes are tired) and this was triggered while driving an hour and a half after she received her first dose, also, tiredness and mild muscle weakness in the shoulder the shot went in. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events triggered migraine with aura, tiredness and mild muscle weakness in the shoulder the shot went in was resolving at the time of this report  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Headache; Muscle and joint pain; Muscle and joint pain; Nausea; Chills; Fatigue; This is a spontaneous report from a contactable consumer (Pfizer employee), the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the right arm on 05May2021 at 16:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included probiotics (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN) and unspecified multivitamin (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 14Apr2021 at 15:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 07:00, the patient experienced headache, muscle and joint pain, nausea, chills and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, muscle and joint pain, nausea, chills and fatigue was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Headache; Muscle and joint pain; Muscle and joint pain; Nausea; Chills; Fatigue; This is a spontaneous report from a contactable consumer (Pfizer employee), the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the right arm on 05May2021 at 16:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included probiotics (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN) and unspecified multivitamin (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 14Apr2021 at 15:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 07:00, the patient experienced headache, muscle and joint pain, nausea, chills and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, muscle and joint pain, nausea, chills and fatigue was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Fatigue, Muscle fatigue, Musculoskeletal stiffness
Clinical narrative: Body aches; Muscle stiffness; Neck stiffness; muscle fatigue; Dizziness; Diarrhea; Exhaustion; Redness around the injection site; Swelling around the injection site; Injection site is also warm to touch; This is a spontaneous report from a contactable healthcare professional, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 30Apr2021 at 15:30 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, polycystic ovarian syndrome, and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included SERTRALINE, TOPAMAX, METFORMIN, and BOTOX for an unknown indications, from an unknown date and unknown if ongoing. The patient previously received RISPERIDONE and experienced drug allergy on an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 09Apr2021 at 15:30 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. On 30Apr2021 at 18:00, the patient experienced body aches, muscle and neck stiffness, muscle fatigue, dizziness, diarrhea, exhaustion/fatigue, redness and swelling around the injection site, and injection site was also warm to touch. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, muscle and neck stiffness, muscle fatigue, dizziness, diarrhea, exhaustion fatigue, redness and swelling around the injection site, and injection site is also warm to touch was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Body aches; Muscle stiffness; Neck stiffness; muscle fatigue; Dizziness; Diarrhea; Exhaustion; Redness around the injection site; Swelling around the injection site; Injection site is also warm to touch; This is a spontaneous report from a contactable healthcare professional, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 30Apr2021 at 15:30 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, polycystic ovarian syndrome, and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included SERTRALINE, TOPAMAX, METFORMIN, and BOTOX for an unknown indications, from an unknown date and unknown if ongoing. The patient previously received RISPERIDONE and experienced drug allergy on an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 09Apr2021 at 15:30 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. On 30Apr2021 at 18:00, the patient experienced body aches, muscle and neck stiffness, muscle fatigue, dizziness, diarrhea, exhaustion/fatigue, redness and swelling around the injection site, and injection site was also warm to touch. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, muscle and neck stiffness, muscle fatigue, dizziness, diarrhea, exhaustion fatigue, redness and swelling around the injection site, and injection site is also warm to touch was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Paraesthesia, Pyrexia, Rash
Clinical narrative: 102.1 fever; Severe joint pain in large and small joints; Tingling; Swelling right lower face; Rash; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 22Apr2021 at 16:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included citalopram (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Apr2021 at 10:00, the patient experienced fever 102.1, severe joint pain in large and small joints, tingling and swelling right lower face and rash. On the same day, the patient underwent body temperature test and the result was 102.1 (unit unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever 102.1, severe joint pain in large and small joints, tingling and swelling right lower face and rash was resolved with sequelae on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: 102.1 fever; Severe joint pain in large and small joints; Tingling; Swelling right lower face; Rash; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 22Apr2021 at 16:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included citalopram (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Apr2021 at 10:00, the patient experienced fever 102.1, severe joint pain in large and small joints, tingling and swelling right lower face and rash. On the same day, the patient underwent body temperature test and the result was 102.1 (unit unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever 102.1, severe joint pain in large and small joints, tingling and swelling right lower face and rash was resolved with sequelae on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Chills, Dizziness
Clinical narrative: She had a fever of 100.3F within 12 hours of having the vaccine the first time; blurred vision; nausea; extreme headache; massive migraine; Unwell; muscle pains and chills; muscle pains and chills; fast heartbeat then the nigh, heart rate is 128 bpm-132 bpm; Injection site pain; Joint pain; vomiting; Tiredness; Dizziness; weakness; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number, and Expiry date: not reported) age at the time of vaccination was 29 years, administered in Arm Left on 07Apr2021 at 09:30 as dose 1, single for COVID-19 immunization. The patient's medical history included thyroid problem about eight years ago that went away. The patient's concomitant medication was not reported. The patient did not take any other vaccine in four weeks prior COVID-19 vaccine. On 07Apr2021, after the first dose the patient had a fever of 100.3 Fahrenheit within 12 hours of having the vaccine the first time. The patient felt unwell causing blurred vision, nausea from extreme headache comparative to a massive migraine, vomiting. The patient had experienced muscle pains and chills. The patient have a fast heartbeat then the night, heart rate of 128 bpm - 132 bpm, tiredness, injection site pain, joint pain, dizziness, and weakness lasted for five days. The Pfizer was unable to make any treatment recommendations for individual patients who may receive the Pfizer vaccine. Clinical judgement made by your physician/HCP based on the medical history and the clinical status of a specific patient should dictate the appropriate actions to be taken. No investigation assessment. Therapeutic measures included IBUPROFEN for fever. The patient underwent lab tests and procedures, which included Fever 100.3 Fahrenheit, heart rate 128 bpm-132 bpm, Covid19 negative on an unknown date in Jun2020, Jan2021. The outcome of the events was fever, dizziness, weakness resolved, blurred vision, migraine, unwell, fast heartbeat then the nigh, heart rate is 128 bpm-132 bpm, was unknown, nausea, headache, muscle pains, chills, Injection site pain, Joint pain, vomiting, and Tiredness was not resolved.  No follow-up attempts were needed, information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Heart rate, Heart rate increased, Malaise
Clinical narrative: She had a fever of 100.3F within 12 hours of having the vaccine the first time; blurred vision; nausea; extreme headache; massive migraine; Unwell; muscle pains and chills; muscle pains and chills; fast heartbeat then the nigh, heart rate is 128 bpm-132 bpm; Injection site pain; Joint pain; vomiting; Tiredness; Dizziness; weakness; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number, and Expiry date: not reported) age at the time of vaccination was 29 years, administered in Arm Left on 07Apr2021 at 09:30 as dose 1, single for COVID-19 immunization. The patient's medical history included thyroid problem about eight years ago that went away. The patient's concomitant medication was not reported. The patient did not take any other vaccine in four weeks prior COVID-19 vaccine. On 07Apr2021, after the first dose the patient had a fever of 100.3 Fahrenheit within 12 hours of having the vaccine the first time. The patient felt unwell causing blurred vision, nausea from extreme headache comparative to a massive migraine, vomiting. The patient had experienced muscle pains and chills. The patient have a fast heartbeat then the night, heart rate of 128 bpm - 132 bpm, tiredness, injection site pain, joint pain, dizziness, and weakness lasted for five days. The Pfizer was unable to make any treatment recommendations for individual patients who may receive the Pfizer vaccine. Clinical judgement made by your physician/HCP based on the medical history and the clinical status of a specific patient should dictate the appropriate actions to be taken. No investigation assessment. Therapeutic measures included IBUPROFEN for fever. The patient underwent lab tests and procedures, which included Fever 100.3 Fahrenheit, heart rate 128 bpm-132 bpm, Covid19 negative on an unknown date in Jun2020, Jan2021. The outcome of the events was fever, dizziness, weakness resolved, blurred vision, migraine, unwell, fast heartbeat then the nigh, heart rate is 128 bpm-132 bpm, was unknown, nausea, headache, muscle pains, chills, Injection site pain, Joint pain, vomiting, and Tiredness was not resolved.  No follow-up attempts were needed, information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Myalgia, Nausea, Pyrexia, SARS-CoV-2 test
Clinical narrative: She had a fever of 100.3F within 12 hours of having the vaccine the first time; blurred vision; nausea; extreme headache; massive migraine; Unwell; muscle pains and chills; muscle pains and chills; fast heartbeat then the nigh, heart rate is 128 bpm-132 bpm; Injection site pain; Joint pain; vomiting; Tiredness; Dizziness; weakness; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number, and Expiry date: not reported) age at the time of vaccination was 29 years, administered in Arm Left on 07Apr2021 at 09:30 as dose 1, single for COVID-19 immunization. The patient's medical history included thyroid problem about eight years ago that went away. The patient's concomitant medication was not reported. The patient did not take any other vaccine in four weeks prior COVID-19 vaccine. On 07Apr2021, after the first dose the patient had a fever of 100.3 Fahrenheit within 12 hours of having the vaccine the first time. The patient felt unwell causing blurred vision, nausea from extreme headache comparative to a massive migraine, vomiting. The patient had experienced muscle pains and chills. The patient have a fast heartbeat then the night, heart rate of 128 bpm - 132 bpm, tiredness, injection site pain, joint pain, dizziness, and weakness lasted for five days. The Pfizer was unable to make any treatment recommendations for individual patients who may receive the Pfizer vaccine. Clinical judgement made by your physician/HCP based on the medical history and the clinical status of a specific patient should dictate the appropriate actions to be taken. No investigation assessment. Therapeutic measures included IBUPROFEN for fever. The patient underwent lab tests and procedures, which included Fever 100.3 Fahrenheit, heart rate 128 bpm-132 bpm, Covid19 negative on an unknown date in Jun2020, Jan2021. The outcome of the events was fever, dizziness, weakness resolved, blurred vision, migraine, unwell, fast heartbeat then the nigh, heart rate is 128 bpm-132 bpm, was unknown, nausea, headache, muscle pains, chills, Injection site pain, Joint pain, vomiting, and Tiredness was not resolved.  No follow-up attempts were needed, information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vision blurred, Vomiting
Clinical narrative: She had a fever of 100.3F within 12 hours of having the vaccine the first time; blurred vision; nausea; extreme headache; massive migraine; Unwell; muscle pains and chills; muscle pains and chills; fast heartbeat then the nigh, heart rate is 128 bpm-132 bpm; Injection site pain; Joint pain; vomiting; Tiredness; Dizziness; weakness; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number, and Expiry date: not reported) age at the time of vaccination was 29 years, administered in Arm Left on 07Apr2021 at 09:30 as dose 1, single for COVID-19 immunization. The patient's medical history included thyroid problem about eight years ago that went away. The patient's concomitant medication was not reported. The patient did not take any other vaccine in four weeks prior COVID-19 vaccine. On 07Apr2021, after the first dose the patient had a fever of 100.3 Fahrenheit within 12 hours of having the vaccine the first time. The patient felt unwell causing blurred vision, nausea from extreme headache comparative to a massive migraine, vomiting. The patient had experienced muscle pains and chills. The patient have a fast heartbeat then the night, heart rate of 128 bpm - 132 bpm, tiredness, injection site pain, joint pain, dizziness, and weakness lasted for five days. The Pfizer was unable to make any treatment recommendations for individual patients who may receive the Pfizer vaccine. Clinical judgement made by your physician/HCP based on the medical history and the clinical status of a specific patient should dictate the appropriate actions to be taken. No investigation assessment. Therapeutic measures included IBUPROFEN for fever. The patient underwent lab tests and procedures, which included Fever 100.3 Fahrenheit, heart rate 128 bpm-132 bpm, Covid19 negative on an unknown date in Jun2020, Jan2021. The outcome of the events was fever, dizziness, weakness resolved, blurred vision, migraine, unwell, fast heartbeat then the nigh, heart rate is 128 bpm-132 bpm, was unknown, nausea, headache, muscle pains, chills, Injection site pain, Joint pain, vomiting, and Tiredness was not resolved.  No follow-up attempts were needed, information about lot/batch number cannot be obtained.